Cymabay Therapeu Ownership
The majority of Cymabay Therapeu outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cymabay Therapeu to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cymabay Therapeu. Please pay attention to any change in the institutional holdings of Cymabay Therapeu as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Cymabay Therapeu in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cymabay Therapeu, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Cymabay |
Cymabay Stock Ownership Analysis
About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.99. Cymabay Therapeu had not issued any dividends in recent years. CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. For more info on Cymabay Therapeu please contact the company at 510 293 8800 or go to https://www.cymabay.com.Cymabay Therapeu Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cymabay Therapeu insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cymabay Therapeu's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cymabay Therapeu insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Robert Wills over six months ago Disposition of 49245 shares by Robert Wills of Cymabay Therapeu at 4.05 subject to Rule 16b-3 | ||
Paul Quinlan over six months ago Disposition of 41824 shares by Paul Quinlan of Cymabay Therapeu at 7.89 subject to Rule 16b-3 | ||
Sujal Shah over six months ago Acquisition by Sujal Shah of 14625 shares of Cymabay Therapeu at 1.06 subject to Rule 16b-3 | ||
Wiggans Thomas G over a year ago Acquisition by Wiggans Thomas G of 14010 shares of Cymabay Therapeu subject to Rule 16b-3 | ||
Stuart Lewis J over a year ago Acquisition by Stuart Lewis J of 215000 shares of Cymabay Therapeu subject to Rule 16b-3 |
Cymabay Therapeu Outstanding Bonds
Cymabay Therapeu issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cymabay Therapeu uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cymabay bonds can be classified according to their maturity, which is the date when Cymabay Therapeu has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world |